solitomab (106) 

Structure	 

ELVMTQSPSS LTVTAGEKVT MSCKSSQSLL NSGNQKNYLT WYQQKPGQPP  50

KLLIYWASTR ESGVPDRFTG SGSGTDFTLT ISSVQAEDLA VYYCQNDYSY 100

PLTFGAGTKL EIKGGGGSGG GGSGGGGSEV QLLEQSGAEL VRPGTSVKIS 150

CKASGYAFTN YWLGWVKQRP GHGLEWIGDI FPGSGNIHYN EKFKGKATLT 200

ADKSSSTAYM QLSSLTFEDS AVYFCARLRN WDEPMDYWGQ GTTVTVSSGG 250

GGSDVQLVQS GAEVKKPGAS VKVSCKASGY TFTRYTMHWV RQAPGQGLEW 300

IGYINPSRGY TNYADSVKGR FTITTDKSTS TAYMELSSLR SEDTATYYCA 350

RYYDDHYCLD YWGQGTTVTV SSGEGTSTGS GGSGGSGGAD DIVLTQSPAT 400

LSLSPGERAT LSCRASQSVS YMNWYQQKPG KAPKRWIYDT SKVASGVPAR 450

FSGSGSGTDY SLTINSLEAE DAATYYCQQW SSNPLTFGGG TKVEIKHHHH 500

HH                                                     502

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

Intra-chain	23-94	151-225	275-349	413-477



N-glycosylation site / Site de N-glycosylation / Posiciun de
N-glicosilaciun

305 (but Pro in 306)

	

WHO 

International Nonproprietary Names Programme	

9537

15/01/2012

		

